- Explain why clinical risk scores primarily capture exposure patterns rather than underlying vascular biology, and discuss the implications of this limitation for precision risk prediction.
- Describe how biomarkers enhance mechanistic resolution of vascular disease, while recognizing their temporal variability and context-dependent limitations.
- Discuss how genetic risk stratification captures lifelong vascular susceptibility, and distinguish this from dynamic or trigger-based risk processes.
- Analyze how artificial intelligence improves predictive discrimination by integrating nonlinear and multidimensional interactions across clinical and biological data layers.
- Articulate how the digital twin paradigm enables trajectory-based, personalized simulation of vascular disease, moving beyond static risk estimation toward dynamic precision modeling.
Session date:
03/10/2026 - 8:00am to 9:00am CDT
Location:
Endeavor Health - Glenbrook Hospital
2100 Pfingsten Rd
Cardiovascular Institute Building, 2nd Floor, Conference Room #2843 (Take Elevator I)
Glenview, IL
60026
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Alfonso Tafur, MD MS MBA

Facebook
X
LinkedIn
Forward